Molycorp (MCP) Given Daily Coverage Optimism Rating of 0.10
News coverage about Molycorp (NYSE:MCP) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Molycorp earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.1902162826514 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Molycorp (NYSE MCP) remained flat at $$0.03 during trading hours on Tuesday. Molycorp has a 52 week low of $0.02 and a 52 week high of $0.12.
COPYRIGHT VIOLATION NOTICE: This story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/11/07/molycorp-mcp-given-daily-coverage-optimism-rating-of-0-10.html.
Molycorp, Inc is a rare earths producer. The Company operates in four business segments: Resources, Chemicals and Oxides, Magnetic Materials and Alloys and Rare Metals. The Resources segment includes its operations at the Mountain Pass facility. The Chemicals and Oxides segment includes the production of rare earths at Molycorp Silmet; production of separated heavy rare earth oxides and other engineered materials from its Molycorp Jiangyin facility, and production of rare earths, salts of rare earth elements (REEs), zirconium-based engineered materials and mixed rare earth/zirconium oxides from its Molycorp Zibo facility.
Receive News & Stock Ratings for Molycorp Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molycorp Inc and related stocks with our FREE daily email newsletter.